The Effect of Combined Dulaglutide and Dapagliflozin Treatment vs DPP-4 Inhibitors in Endothelial and Vascular Function in Patients With Type 2 Diabetes Mellitus and Albuminuria
Clinical trial NCT06611904 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06611904
- Sponsor
- Attikon Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-01
- Primary completion
- 2022-02-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.